Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Linagliptin slows down premature aging in certain mice.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Upadacitinib effectively treats pyoderma gangrenosum.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Dutasteride may help reduce brain inflammation and improve cognition.

The new gel for hair loss is safe, effective, and reduces side effects.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Upadacitinib improved multiple immune-related conditions in one patient.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

Deucravacitinib helped a man regrow hair and improve psoriasis.